Janus Henderson Global Life Sciences Fund Class C (JFNCX) Stock Overview
Explore Janus Henderson Global Life Sciences Fund Class C’s financial performance, market position, analyst ratings, and future outlook.
Janus Henderson Global Life Sciences Fund Class C (JFNCX)
Key Financials
Key Financials
Market Cap
6.2B
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
N/A
JFNCX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Janus Henderson Global Life Sciences Fund Class C's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of JFNCX on the NASDAQ shows an RSI of 61.57, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $70.96 for the NASDAQ listing.
Key metrics behind Janus Henderson Global Life Sciences Fund Class C's NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 6.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of JFNCX on the NASDAQ.